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Abstract
Objective. With the increasing societal awareness
of the prevalence and impact of acute pain, there is
a need to develop an acute pain classification sys-
tem that both reflects contemporary mechanistic in-
sights and helps guide future research and
treatment. Existing classifications of acute pain
conditions are limiting, with a predominant focus
on the sensory experience (e.g., pain intensity) and
pharmacologic consumption. Consequently, there
is a need to more broadly characterize and classify
the multidimensional experience of acute pain.
Setting. Consensus report following expert panel
involving the Analgesic, Anesthetic, and Addiction
Clinical Trial Translations, Innovations,
Opportunities, and Networks (ACTTION), American
Pain Society (APS), and American Academy of Pain
Medicine (AAPM).
Methods. As a complement to a taxonomy recently
developed for chronic pain, the ACTTION public-
private partnership with the US Food and Drug
Administration, the APS, and the AAPM convened a
consensus meeting of experts to develop an acute
pain taxonomy using prevailing evidence. Key
issues pertaining to the distinct nature of acute
pain are presented followed by the agreed-upon tax-
onomy. The ACTTION-APS-AAPM Acute Pain
Taxonomy will include the following dimensions: 1)
core criteria, 2) common features, 3) modulating
factors, 4) impact/functional consequences, and 5)
putative pathophysiologic pain mechanisms.
Future efforts will consist of working groups utiliz-
ing this taxonomy to develop diagnostic criteria for
a comprehensive set of acute pain conditions.
Perspective. The ACTTION-APS-AAPM Acute Pain
Taxonomy (AAAPT) is a multidimensional acute
pain classification system designed to classify
acute pain along the following dimensions: 1) core
criteria, 2) common features, 3) modulating factors,
4) impact/functional consequences, and 5) putative
pathophysiologic pain mechanisms.
Conclusions. Significant numbers of patients still
suffer from significant acute pain, despite the advent
of modern multimodal analgesic strategies.
Mismanaged acute pain has a broad societal impact
as significant numbers of patients may progress to
suffer from chronic pain. An acute pain taxonomy pro-
vides a much-needed standardization of clinical diag-
nostic criteria, which benefits clinical care, research,
education, and public policy. For the purposes of the
present taxonomy, acute pain is considered to last up
to seven days, with prolongation to 30 days being
common. The current understanding of acute pain
mechanisms poorly differentiates between acute and
chronic pain and is often insufficient to distinguish
among many types of acute pain conditions. Given
the usefulness of the AAPT multidimensional frame-
work, the AAAPT undertook a similar approach to
organizing various acute pain conditions.
Key Words. Acute Pain, Taxonomy, ACTTION, biop-
sychosocial, AAAPT, AAPT
Introduction
In contrast with the pathophysiologic state of chronic
pain, acute pain is one of life’s inevitable core experi-
ences and has been evolutionarily preserved to serve a
critical role in protecting the host against a myriad of
threats. Despite this critical role in protecting the host,
acute pain can be associated with suffering and a re-
duction in physical function and productivity—thereby
causing a significant burden on the person, their family,
and society as a whole. It is now appreciated that acute
pain represents a major public health problem.
One of the challenges to both researchers and clinicians
is in understanding the distinction between acute and
chronic pain. This distinction is important as a better
understanding of acute pain may help us to devise
therapies to prevent the development of chronic pain.
Furthermore, better classification of these pain condi-
tions will help promote more safe, effective, and tar-
geted treatments for individuals suffering from acute
pain. Unfortunately, we currently lack precision when
Kent et al.
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discussing the measurement, treatment, research, or
even public policy related to acute pain. We therefore
need an organized taxonomy of acute pain that estab-
lishes a set of common concepts, diagnostic criteria,
features, and mechanisms that defines and categorizes
the multidimensional aspects of acute pain. This classifi-
cation will then promote future research into mechan-
isms, prevention, and treatments for acute pain.
In 2012, an effort to enhance the precision of dialogue
about chronic pain was initiated by the Analgesic,
Anesthetic, and Addiction Clinical Trial Translations,
Innovations, Opportunities, and Networks (ACTTION) and
the American Pain Society (APS). This initiative subse-
quently developed the ACTTION-APS Pain Taxonomy
(AAPT) with the objective of creating an “evidence-based
chronic pain taxonomy based on a consistently applied
multidimensional framework” [1]. Taxonomy in this sense
refers to an organization of concepts arranged using hier-
archal relationships. The AAPT sought to develop a hier-
archical arrangement of characteristics of chronic pain
conditions to address the research, clinical, and regulatory
limitations of the International Association for the Study of
Pain (IASP) taxonomy of pain. AAPT performed this by
providing a “standardized, systematic, and evidence-
based approach to pain classification that incorporates in-
formation regarding biopsychosocial mechanisms and that
can be applied to all common chronic pain conditions” [2].
AAPT developed an approach that included five dimen-
sions that incorporated emerging evidence while retain-
ing some conceptual features of existing chronic pain
classifications. (Table 1). Further, AAPT proposed spe-
cific categories of chronic pain conditions (i.e., periph-
eral and central nervous system; musculoskeletal;
orofacial and cranial; visceral, pelvic, and urogenital
pain; and disease-associated pains not otherwise speci-
fied) that would each be characterized along the five
AAPT dimensions by separate working groups.
In 2014, discussions began among APS, ACTTION, and
the AAPM about the value of developing a taxonomy of
acute pain. Such discussions were spurred by a resur-
gent interest in acute pain, including increased recogni-
tion of the societal burden of the transition from acute
to chronic pain, and recognition by a coauthor (DBC) of
the unique opportunity for these three organizations to
collaborate on such a taxonomy. While a prior working
definition of acute pain was formulated by the AAPM
Acute Pain Medicine Special Interest Group in 2015
(Table 2), it was apparent that work was needed to fur-
ther characterize the complex nature of acute pain. A
preliminary step in conducting this work was a state-of-
the-science expert report that summarized existing lit-
erature to inform practice education, research, and
health policy [3]. The report included an important ob-
servation that the organization and integration of acute
Table 1 The ACTTION-APS Chronic Pain Taxonomy (AAPT) multidimensional framework
Dimension Description
1. Core diagnostic criteria Symptoms, signs, and diagnostic test findings required for the
diagnosis of the chronic pain condition. Includes differential
diagnosis considerations [61].
2. Common features Additional information regarding the disorder, including common
pain characteristics (e.g., location, temporal qualities, descriptors),
nonpain features (numbness, fatigue), the epidemiology of the
condition, and life span considerations, including those specific
to pediatric and geriatric populations. These features are important
in describing the disorder but are not components of the core
diagnostic criteria [61,62].
3. Common medical and psychiatric
comorbidities
Medical and psychiatric disorders that commonly occur with the
chronic pain condition. For example, major depression is comorbid
with many chronic pain conditions. Also includes chronic overlapping
pain conditions, that is, those chronic pain conditions that are
comorbid with each other [63].
4. Neurobiological, psychosocial, and
functional consequences
Neurobiological, psychosocial, and functional consequences of
chronic pain. Examples include sleep and mood disorders and
pain-related interference with daily activities [64,65].
5. Putative neurobiological and psychosocial
mechanisms, risk factors, and
protective factors
Putative neurobiological and psychosocial mechanisms contributing
to the development and maintenance of the chronic pain condition,
including risk and protective factors. Examples include central
sensitization, decreased descending inhibition, and somatosensory
amplification [66].
This table was reused with permission from Dworkin et al. Multidimensional diagnostic criteria for chronic pain: Introduction to
the ACTTION–American Pain Society Pain Taxonomy (AAPT). J Pain 2016;17(9 suppl):T1–T9.
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pain science has been hampered by the lack of a taxo-
nomic structure necessary to promote widespread util-
ization and acceptance [3]. Given the AAPT’s previous
success in defining a taxonomy of chronic pain, a simi-
lar methodology was proposed for the creation of a tax-
onomy of acute pain: the ACTTION-APS-AAPM Pain
Taxonomy (AAAPT) for Acute Pain. The principal object-
ive of the first AAAPT meeting was to review the AAPT
taxonomy for chronic pain and determine its appropri-
ateness, applicability, and adaptability if extended to
acute pain.
Importance of an Acute Pain Ontology/Taxonomy
Prevalence of Acute Pain
Despite advances in multimodal analgesia, acute pain
remains a pervasive source of suffering. Work by
Apfelbaum et al. in 2003 demonstrated that 80% of pa-
tients suffered acute pain after surgery, and that 86% of
these patients reported moderate, severe, or extreme
pain [4]. Moreover, the majority of these patients experi-
enced worse pain following discharge from the hospital.
More recent work by Buvanendran in 2015 demon-
strated that 66% of patients reported moderate, severe,
or extreme pain after surgery and 59% of patients re-
ported moderate, severe, or extreme pain during the
first two weeks following hospital discharge [5]. Within
emergency departments, acute pain accounts for up to
78% of visits, with a reported median pain intensity of 8
out of 10 on an 11-point numeric rating scale (NRS) [6–
9]. Finally, primary care physicians commonly encounter
challenging acute pain scenarios (e.g., subacute
postsurgical pain, acute exacerbations of chronic back
pain, acute pharyngitis). In a prospective survey of gen-
eral practitioners providing acute pain management of
ambulatory postsurgical patients, Robaux et al. demon-
strated a significant need for education and guidelines
addressing the diagnosis, optimal treatment, and ex-
pected time course for acute pain conditions presenting
to the primary care setting [10].
Societal and Clinical Impact
The Institutes of Medicine’s (IOM’s) report Relieving Pain
in America: A Blueprint for Transforming Prevention,
Care, Education, and Research drew attention to pain
as a major health problem and placed it on the national
agenda [11]. This report called for work to promote tan-
gible objectives to advance pain treatment, education,
and research and acknowledged that not all acute pain
is being effectively managed. Such efforts are necessary
because those with acute pain are currently not offered
comprehensive, integrated, evidence-based assessment
and treatments.
Acute pain has broader societal impact beyond the initial
suffering imparted by the originating insult. Inadequately
managed acute pain can lead to patient dissatisfaction,
pathophysiologic sequelae, and maladaptive behaviors
[12]. With musculoskeletal conditions alone, one in four
patients progresses from acute to chronic pain, contri-
buting to serious long-term pain and pain-related phys-
ical disability [13]. The US Department of Health and
Human Services National Pain Strategy and the Centers
for Disease Control and Prevention (CDC) guidelines on
opioid prescriptions for chronic noncancer pain, both re-
cently released, emphasize that chronic pain begins with
acute pain [14,15]. However, the transition from acute to
chronic pain remains difficult to predict and little is
known about how to prevent its development [16].
Conversely, unintended consequences of the treatment
of acute pain can directly threaten patient safety. For ex-
ample, there exists a wealth of data on the cardiovascu-
lar, renal, and gastrointestinal adverse events associated
with nonsteroidal anti-inflammatory drugs (NSAIDS), and
the risk of hepatic toxicity from over-the-counter anal-
gesics containing acetaminophen remain a substantial
public health problem [17–20]. Public policy debates on
acute pain in the United States have recently centered
on opioid analgesics and their effects both on near-term
patient safety (e.g., respiratory depression, cognitive
dysfunction) and longer-term issues of opioid use dis-
orders. It is well known that patients who develop opioid
use disorders often have their first exposure to opioids
during an acute pain episode [21,22]. With increasing
numbers of surgeries and the push to better control
pain, there are concerning trends about increases in
both number and dosage of opioid prescriptions follow-
ing surgery and their contribution to the US opioid epi-
demic [23]. Researchers have recently identified certain
surgeries and patient vulnerabilities that are associated
with increased likelihood of being on persistent opioids
after surgery [24–27]. However, much research is
needed to determine if preventive strategies can reduce
the development of opioid use disorders. An acute pain
taxonomy would be an important part of that effort.
Do Any Acute Pain Taxonomies Exist?
The literature on acute pain assessment and treatment
largely focuses on acute pain intensity (e.g., as assessed
by numerical rating scales, verbal rating scales, visual
analog scales, various facial scales, or observational
pain scales), reflecting a one-dimensional approach to
acute pain [28]. Such approaches are in keeping with
the recommendations of multiple organizations in the
Table 2 AAPM acute pain SIG working definition
of acute pain
AAPM APMSIG working definition: Acute pain
Acute pain is the physiologic response to and experience
of noxious stimuli that can become pathologic, is normally
sudden in onset, time limited, and motivates behaviors to
avoid potential or actual tissue injury.
Kent et al.
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1990s advocating for clinically feasible, standardized
approaches to pain assessment, further promulgated by
core measures utilized in single-dose analgesic trials
[29]. Recent studies have expanded such assessments,
classifying the acute “pain experience” through a variety
of approaches such as multidimensional pain-related
patient-reported outcomes and trajectories [30].
However, no comprehensive frameworks exist that in-
corporate mechanistic information in conjunction with
pain experience, functional consequences, and psycho-
logic/social impact (i.e., biopsychosocial experience)
indexed to a standardized array of acute pain conditions.
Further, while numerous sources (e.g., textbooks, con-
ference proceedings) have provided groupings of acute
pain conditions (i.e., postsurgical pain, ischemic pain,
musculoskeletal pain), such groupings are not unified
within a taxonomy.
Impact on Research and Education Initiatives
Not only would the creation of an acute pain taxonomy
provide a much-needed standardization of clinical diag-
nostic criteria, it also would benefit research and educa-
tion. Numerous documents describe the optimization of
acute pain trial designs and call attention to gaps in
both the assessment and treatment of acute pain
[29,31]. For example, Gordon et al. described a need
for future randomized controlled trials (RCTs) and obser-
vational studies to include patients with defined pheno-
types [31]. At present, the majority of acute pain studies
lack the foundation of a comprehensive acute pain tax-
onomy to codify inclusion and exclusion criteria and
generally do not capture the biopsychosocial outcomes
(e.g., pain behavior, pain interference, physical function,
sleep disturbance, self-efficacy, social satisfaction, etc.)
related to acute pain [32]. For example, a recent meta-
analysis of 15 RCTs addressing acute postmastectomy
pain shows a predominant focus on pain intensity with
little mention of functional or biopsychosocial measures
[33]. However, a growing number of investigations are
utilizing multidimensional measures to predict postop-
erative outcomes and embrace such measures to deter-
mine analgesic efficacy [34–37]. Thus, beyond
establishing a framework for inclusion and exclusion cri-
teria, an evidence-based acute pain taxonomy offers the
potential to illuminate the complex biopsychosocial ex-
perience of acute pain and encourage research to move
beyond unidimensional measures of pain intensity.
Importantly, a multidimensional approach to an acute
pain taxonomy would also provide an essential founda-
tion for training acute pain medicine physicians. In 2014,
the Accreditation Council for Graduate Medical Education
(ACGME) Board of Directors voted to accept Regional
Anesthesia and Acute Pain Medicine as an accredited fel-
lowship, a move that was later approved in October
2016. Since that time, significant effort has led to the cre-
ation of a set of competencies embracing the compre-
hensive practice of acute pain medicine. An evidence-
based acute pain taxonomy will advance the structure
and content of this curriculum. Moreover, this structure
will support ongoing efforts to bolster pain education
across medical specialties and ancillary services.
Acute Pain Taxonomy Considerations:
Differentiating Acute from Chronic?
The AAAPT Steering Committee convened a meeting
of experts in April of 2016 with the goal of addressing
the need for a comprehensive acute pain taxonomy.
This two-day conference began with discussions on 1)
the need for formal taxonomies for pain and 2)
whether initial efforts in developing a taxonomy for
chronic pain by the AAPT could serve as a basis for
developing an acute pain taxonomy. Presentations on
the historical contexts of acute pain through both an-
cient and modern history segued into a review of
known biological mechanisms of acute pain (Table 3).
Discussions then turned to principles of taxonomic or-
ganization and the validity and reliability of diagnostic
criteria as a means of informing further development.
Following discussions focused on specific types of
acute pain including postoperative pain, acute pain
related to trauma and burn, visceral pain, acute cancer
pain, acute neuropathic pain, acute musculoskeletal
pain, acute orofacial pain, and acute pain in special
populations such as pediatrics. These discussions cul-
minated in a group discussion on developing a multidi-
mensional structure for acute pain taxonomy based on
the AAPT chronic pain initiative.
Time-Based Criteria
In the AAAPT discussions, differentiation of acute pain
from chronic pain quickly emerged as a principal topic,
Table 3 Presentation topics during AAAPT
taxonomy development meeting
Presented topics
AAPT chronic pain effort (RF/RD)
Distinctions among acute, subacute, and
chronic pain (DC)
Pathophysiologic mechanisms and acute pain
conditions (TB)
Taxonomy of acute pain conditions (PT)
Acute surgical/procedural pain (CW)
Acute trauma pain (CB)
Acute musculoskeletal pain (SS)
Acute visceral pain (MK)
Cancer/immune mediated acute pain (KT)
Acute neuropathic pain (SR)
Acute orofacial pain (PD)
Acute pain in pediatric, geriatric, and special
populations (SW)
Approached to providing an evidence base for acute pain
diagnostic criteria (SB)
AAAPT Acute Pain Taxonomy
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with an emphasis on timing as a key differentiator.
Historically, the Food and Drug Administration has sug-
gested that pain occurring within 30 days of an insult or
injury is considered acute pain and that after 90 days
postinjury/-insult such pain is referred to as chronic pain
[32,38]. Recent CDC guidelines pertaining to opioid pre-
scriptions posit a 72-hour period for acute pain treat-
ment of nontraumatic and nonsurgical origins [14].
Other experts have variously characterized durations of
acute pain ranging from seven to 14 days, with numer-
ous examples throughout the perioperative, emergency
department, and primary care settings. The heterogen-
eity of definitions of acute pain with respect to delinea-
tions of time intervals, as well as clinical contexts and
excluded patient populations, highlights the gaps and
opportunities raised with most of the a priori time
thresholds.
In the search for a definitive cut-point between acute
and chronic pain, it is important to consider the per-
spective that acute and chronic pain are not entirely
“separate” entities, but rather different aspects along a
continuum of pain [39]. This continuum may extend be-
yond established characteristics of intensity and timing;
for instance, contexts such as initial pain intensity rat-
ings may influence the segue between acute and
chronic [40]. Given the perspective of a continuum from
acute to chronic pain, a clear separation of acute from
chronic pain may be impossible, and a focus on “at
what time” acute pain becomes chronic may be mis-
guided or misleading and unnecessary. At present, the
vague and ill-defined term “subacute” pain has been
used to define this time period where acute pain may or
may not become chronic pain. Unique attributes of pain
during this period, however, have been described. For
example, in a study of 96 patients undergoing total
knee arthroplasty, more patients described neuropathic
pain symptoms at six weeks postoperatively when com-
pared with the immediate postoperative setting or at
later time points greater than six months [41]. At this
time, the term “subacute” is used only descriptively until
this period can be more precisely characterized mech-
anistically and phenomenologically.
Our evolutionary approach thus follows that of the AAPT
effort on chronic pain; we simply do not have sufficient
mechanistic data at this time to render a “revolutionary”
consideration of the acute to chronic transition. Given
numerous examples of prolonged and/or repetitive noci-
ception/pain events that do not progress into chronic
pain, future iterations of the AAAPT taxonomy may be
able to better focus on the “why” and “how” for the
transition between acute and chronic pain rather than
solely its temporal parameters.
Despite concerns regarding a formal cutoff point for
acute pain, AAAPT adopted the following time-based
definition of acute pain for pragmatic and heuristic pur-
poses at this time:
Acute pain is considered to last up to seven days, with
the following qualifications:
1. Its duration reflects the mechanism and severity of
the underlying inciting event.
2. Prolongations from seven to 30 days are common.
3. Prolongations beyond the duration of acute pain but
not extending past 90 days postonset/-injury are
common. This refers to the ill-defined but important
period of “subacute” pain that warrants further speci-
fication and consideration in future taxonomic, re-
search, and regulatory efforts.
4. Our understanding of pain mechanisms is currently
insufficient to link these durations to specific physio-
logic mechanisms.
Unique Attributes of Acute Pain
Apart from the temporal differentiation separating acute
and chronic pain, there are other characteristics that dif-
ferentiate the two conditions. One of the foremost differ-
ences between acute and chronic pain remains the
ambiguity of its contextual meaning. Acute pain has
often been considered a protective mechanism against
further injury that may facilitate recovery from injury.
Those aspects of acute pain that are normative, protect-
ive, and helpful deserve special attention as they con-
trast starkly with chronic pain, which is invariably
considered pathologic with no direct benefit to the pa-
tient. Such contrasts are not unique to acute and
chronic pain. For instance, immune function and inflam-
mation are generally considered normative, protective
responses against insults yet can generate pathologic
states that are life-threatening (e.g., sepsis, autoimmune
disease) [42,43]. Notably, as with allergy, inflammation,
anaphylaxis, and sepsis, the transition points seem key,
yet the nature of the points of inflection remains
enigmatic.
Mechanism-Based
Similar to the AAPT chronic pain experience, it was
hoped that the AAAPT could inform its dimensional con-
structs by mapping onto underlying pain mechanisms.
As with chronic pain, it was agreed that the current
understanding of acute pain mechanisms poorly differ-
entiates between acute and chronic pain and is often in-
sufficient to distinguish among many types of acute pain
conditions. One of the foremost examples of such a fail-
ure is the intertwined nature of the pathophysiologic
mechanisms (e.g., nociceptive, neuropathic, inflamma-
tory, ischemic) contributing to acute pain. As each of
these components is present in nearly all acute pain
conditions, distinguishing among acute pain conditions
according to their nociceptive, neuropathic, or inflamma-
tory components is presently infeasible. A similar issue
arises in considering biochemical mediators as current
evidence suggests that acute and chronic disease
Kent et al.
952
states often display similar profiles of peripheral
mediators.
Another approach to differentiate between acute and
chronic pain, or among acute pain types, is to consider
whether the mechanism of sensitization is peripheral or
central. Although acute pain may initially involve promin-
ent peripheral sensitization, it may also occur during
chronic pain and therefore discourages reliance on the
criterion of peripheral sensitization as a key differentiator
between acute and chronic pain. On the other hand,
central sensitization seems to play a larger role (and has
been characterized more extensively) in chronic pain
conditions but yet is evident in acute pain as well.
Future research will be needed to better characterize
the relative contributions of peripheral and central sensi-
tization to the overall acute pain process—and its transi-
tion to chronic pain.
The presence and nature of tissue injury probably differ-
entiates best between acute and chronic pain, as well
as among different types of acute pain conditions. At
the level of tissue injury, distinct profiles of injured struc-
tures, tissue-specific mediators, receptors, and re-
sponses may help differentiate acute pain conditions.
For instance, the high affinity receptor (trkA) for the noci-
ceptive mediator nerve growth factor (NGF) is expressed
in notably higher levels in visceral bladder afferent vs cu-
taneous sensory afferents [44]. Further, acute pain
stemming from periosteal injury has distinct mechan-
isms, mediators, and transmission compared with acute
pain stemming from cutaneous injury. While many ex-
amples of acute tissue injury involve damage to an array
of tissues (post-traumatic or postsurgical models), other
etiologies are more tissue specific. For example, acute
neuropathic pain may be in part initiated by infectious
and inflammatory injury, more specifically to neural
structures such as dorsal root ganglion neurons.
Similarly, certain types of acute pain are strongly associ-
ated with a particular anatomic location, for example,
fracture or burn pain.
Dimensional Considerations
Given the usefulness of the AAPT multidimensional
framework, the AAAPT undertook a similar approach to
organizing various acute pain conditions. In the consen-
sus approach that emerged from the AAAPT discus-
sions, acute pain and chronic pain are considered
subclasses of pain. Acute pain conditions are broadly
characterized according to the five dimensions that are
described below. Specific categories of prototypical
acute pain conditions would be differentiated according
to these five dimensions. Notably in this construct, each
dimension can be further organized as needed during
future iterations. A strategic decision was made to defer
discussions on acute pain assessment and treatment
for a future effort.
Dimensions
Discussion on how to categorize acute pain conditions
began with the five dimensions used for the AAPT.
These were extended to consider 10 to 12 dimensions,
before then collapsing back to a final five dimensions
aligned with, but differing from, the AAPT chronic pain
dimensional framework. The rationale for this approach
included recognition of the close link between acute
and chronic pain and the potential benefits of aligning
their dimensional structures for research and practice
updates. The AAAPT specified that no one dimension
be considered more important than or superior to the
others. The five dimensions for the AAAPT were finalized
as 1) core criteria, 2) common features, 3) modulating
factors, 4) impact/functional consequences, and 5) pu-
tative pathophysiologic pain mechanisms. (Table 4)
Dimension 1: Core Criteria
The core criteria represent the key features of a given
acute pain condition that permit it to be diagnosed and
distinguished from other acute pain conditions. Unlike
the AAPT dimension 1 for chronic pain, which empha-
sizes the clinical features of the pain condition itself, the
core criteria here put greater emphasis on the nature of
the inciting event. This is because, in many cases, dis-
tinct acute pain conditions may not differ so much in
their characteristic signs and symptoms, but rather, in
their inciting event, a feature not always identifiable in
chronic pain. Moreover, the inciting event would often
be associated with a specific International Classification
of Disease Version 10 (ICD10x) diagnostic or procedure
code that in turn would link the acute pain taxonomy to
established diagnostic and procedural ontologies. The
international standardization of the ICD system links this
dimension to a broader array of efforts to codify various
classification systems used throughout health care. This
feature also permits the AAAPT taxonomy to align with
existing clinical entities. Further, this approach enables a
mechanism to remap the existing dimensional frame-
work to future disease classification schemas according
to the prescribed approaches normally specified during
such ICD transitions.
Another key aspect of dimension 1 is the time elapsed
from the inciting event to the observation of the patient,
which is critical for defining the condition as “acute.” If
not specified, the time from the inciting event within this
framework is presumed to follow the proposed time-
based criteria for acute pain described above.
The core criteria are intended to be the defining aspects
of each condition. They differ from dimension 2: com-
mon features, in that the latter is intended to be a more
comprehensive and descriptive collection of characteris-
tics of each acute pain condition that are not necessary
for a diagnosis.
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Dimension 2: Common Features
Attributes of this dimension include common pain-
related signs, symptoms, and qualities of each acute
pain condition. Special emphasis was placed on three
additional attributes in this category: temporal trajectory,
spatial and anatomical distribution, and anticipated re-
covery. Current and anticipated temporal trajectories
(i.e., characteristic changes in a given pain measure
over time in the acute phase) are key elements given
their impact on both treatment and the acute-to-chronic
transition. Likewise, spatial and anatomical distribution
is intended to reflect not only radiation but also periph-
eral, and potentially central, sensitization. Anticipated re-
covery refers to the expected duration of recovery, but
could also be considered a binary response. For ex-
ample, patients suffering from an uncomplicated ankle
sprain will substantially recover pre-injury function, while
patients suffering from hemipelvectomy for sarcoma will
likely suffer from persistent pain and loss of functioning
stemming in part from this pain. Although it is a specific
attribute distinct from other features, anticipated recov-
ery is frequently impacted by core criteria (dimension 1),
modulating factors (dimension 3), impact/functional con-
sequences (dimension 4), and putative pain pathophy-
siologic mechanisms (dimension 5).
Dimension 3: Modulating Factors
Modulating factors include not only comorbid medical
conditions, but also sociodemographic, biological, clin-
ical, behavioral, and affective conditions likely to modu-
late the acute pain experience (e.g., pain
catastrophizing, state anxiety, opioid tolerance, evidence
of central sensitization, adverse childhood experiences)
[35,36,45–47]. These factors may include factors per-
taining to spatiotemporal summation and diffuse noxious
inhibitory control, which more recently has been termed
conditioned pain modulation to specify “psychosocial
paradigms in which a conditioning stimulus is used to
affect a test stimulus” [48–51]. Dimension 3 strongly
considers the context of the inciting event. This context
includes not just the events surrounding the inciting
event of dimension 1, but also the social setting in
which the patient lives and works. Such environmental
factors may extend to the treatment environment and
clinicians that may influence which diagnostic and thera-
peutic interventions are offered. For example, following
a significant acute pain event, availability of analgesic
modalities/techniques is highly dependent on the envir-
onment of care (clinic, rural hospital, large tertiary care
center). Previous pain experiences may be included
here. Finally, a variety of neurobiological mechanisms
may also modulate the acute pain experience. While far
from condition specific, such mechanisms may serve as
risk factors for significant acute pain by either impacting
pain sensitivity (e.g., genetic variants of COMT, TRPA1)
or influencing treatment options such as in drug metab-
olism/receptor interaction (e.g., genetic variants of
CYP2D6, OPRM1) [52–56].
Dimension 4: Impact/Functional Consequences
The fourth dimension describes the recovery trajectory
including the interrelations of physical, social, psycho-
logic, and vocational consequences resulting from the
acute pain condition. This dimension highlights that in
acute pain syndromes the acute pain itself may not be
the principal factor requiring attention, but rather an im-
portant hurdle to recovery from the principal diagnosis/
procedure. For example, patients undergoing total hip
arthroplasty reporting severe pain also report significant
disturbances in social relations and mood [57].
Operationally, the National Pain Strategy has taken the
step of defining “high-impact chronic pain” as “being
associated with substantial restriction of participation in
work, social, and self-care activities for six months or
Table 4 AAAPT acute pain dimensions
Dimension 1: Core criteria Specifies the inciting event, timing from the event, and tissue involved.
Inciting events descriptions include ICD10x diagnostic and/or procedure
codes where possible.
Dimension 2: Common features Characterizes the acute pain condition through common pain variables
(symptoms, signs, quality). Emphasizes temporal trajectory, physical spatial
distribution, and recovery expectations.
Dimension 3: Modulating factors Includes comorbidities (i.e., opioid tolerance) as well as sociodemographic,
biopsychosocial, and surgical factors that may modulate the acute pain experience.
Biopsychosocial risk factors (e.g., catastrophizing) for significant acute pain are
considered here.
Dimension 4: Impact/functional
consequences
Describes the recovery trajectory including the interrelations of physical, social,
psychologic, and vocational consequences resulting from the acute pain condition.
Dimension 5: Putative
mechanisms
Includes the neurobiological mechanisms related to the acute pain condition.
Considers all phases of the acute pain experience and identifies risk factors for
development of significant acute pain. Addresses genetic- and mechanism-based
processes to guide treatment.
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more.” Similar definitions could also be applied to “high-
impact acute pain.”
Dimension 5: Putative Pain Pathophysiologic
Mechanisms
When possible, this dimension characterizes pain-
relevant neurobiologic pathways prior to, during, and
after the inciting event. This dimension delineates the
step-by-step natural history of nociceptive, neuropathic,
and inflammatory processes that occur at the site of in-
jury, extending through cerebral processing. One ex-
ample would be activation of visceral nociceptive
afferents (e.g., TRPV1 activation in urothelial cells) that
transmit noxious stimuli via autonomic ganglia through a
variety of spinal pathways (e.g., spinohypothalamic) ul-
timately processed in cerebral locations such as the an-
terior cingulate gyrus [58–60]. While we lack the
knowledge to classify acute pain conditions on a purely
mechanistic basis and many overlapping mediators
exist, such condition-specific descriptions provide a
platform for future research and clarification. Further,
while the exact processes underlying the transition from
acute to chronic pain remain nebulous, initial iterations
of this taxonomy will consider descriptions of such
postulated mechanisms (e.g., peripheral/central sensi-
tization) for at-risk acute pain conditions (e.g., amputa-
tion, thoracotomy, polytrauma).
Acute Pain Categories
Organization of specific prototypical acute pain condi-
tions diverged from the AAPT model in allowing two
broad categories, within which particular conditions
would be placed (Table 5). The first category specifically
considers acute pain related to surgery, including pro-
cedural pain. Within this category fall acute pain condi-
tions related to different types of surgery, such that
acute pain from appendectomy could be differentiated
from acute pain from thoracotomy, knee replacement,
or cesarean delivery. For current purposes, we use the
term “procedural pain” to refer to acute pain that exists
during the time of a procedure itself, implying the ex-
pectation of minimal to no postprocedural discomfort.
Examples of this might include percutaneous insertion
of an intravenous catheter, endoscopy, cardiac cath-
eterization, or extracorporeal shock wave lithotripsy.
One critical rationale for this differentiation between sur-
gical and nonsurgical categories of acute pain pertains
to the timing, anticipation, and possible preventive as-
pects of scheduled tissue injury. Importantly, this sched-
uling permits the opportunity to intervene prior to the
onset of and during tissue injury and to prospectively
plan for analgesia and functional recovery in the time
immediately following injury. From a mechanistic stand-
point, intervention to decrease acute pain in the peri-
operative/periprocedural period may be key in the effort
to block the transition to chronic pain. However, further
specification will be necessary to address the role of tis-
sue injury and pain that predates the surgery itself.
The second category comprises acute pain related to
nonsurgical etiologies. This is a large category, and thus
subcategories of nonsurgical pain include trauma
(including burn), visceral, ischemic, orofacial, acute
neuropathic, and musculoskeletal, as manifested in the
population at large or in special populations (labor, sickle
cell, pediatrics, etc.). Similar to the aforementioned
chronic pain taxonomy, this approach is admittedly im-
perfect as many of the above acute pain conditions
share overlapping characteristics with surgical acute
pain (i.e., traumatic laceration vs surgical incision).
Two important nonsurgical categories, visceral and is-
chemic pain, illustrate this overlap. Numerous surgical
interventions contain these pain types as subcompo-
nents. For example, surgical bowel intervention often
leads to acute visceral pain. Additionally, conditions
such as spontaneous and traumatic limb or abdominal
compartment syndrome, while largely ischemic in na-
ture, are often surgically related. Commentary on such
mechanisms will certainly be required in the future work-
ing groups addressing surgical subtypes. However,
given the significant number of discrete acute visceral
(e.g., renal colic) and ischemic (e.g., myocardial ische-
mia) conditions that are not necessarily surgical in na-
ture, these were considered appropriate initial
components of the nonsurgical categories. Indeed, the
Table 5 Acute pain categories to be defined
under dimensional structure in future working
groups
Acute pain categories
Surgical/procedural Nonsurgical
Cardiovascular surgery Acute neuropathic
(e.g., radiculopathy)Dental surgery
Acute ischemic (e.g.,
myocardial ischemia)
General surgery
Visceral (e.g., renal colic)
Neurosurgery
Trauma (including burns)
Obstetric/gynecologic
surgery
OrofacialOphthalmic surgery
MusculoskeletalOrthopedic surgery
Special populationsOtolaryngology
AdolescentOut of operating
room procedures Cancer
Pediatric surgery Elderly
Plastic and
reconstructive surgery
Labor
Thoracic surgery
Pediatric/neonatal/fetal
Transplant surgery
Sickle Cell
Urology
Other
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context, environment, and psychosocial modulating fac-
tors may account for greater individual variability of the
pain experience than currently available mechanistic
characterization of such overlapping conditions.
Further development of the description and taxonomy of
all specific acute pain subcategories will be carried out by
several ongoing AAAPT workgroups. Each acute pain
condition will be described according to the five AAAPT
dimensions, with additional characterization as needed.
Conclusion
This multidimensional framework proposed by the AAAPT
provides a taxonomy of acute pain that will allow the vari-
ous acute pain conditions to be characterized in a uni-
form fashion. This acute pain taxonomy is intended to be
a dynamic framework that may continually evolve along-
side ever-emerging evidence on the nature and impact of
acute pain. While separate from the AAPT taxonomy of
chronic pain conditions, the long-term vision is to estab-
lish sufficient understanding of pain such that a standard,
unifying model can evolve, linking the proposed dimen-
sions of both the acute and chronic pain taxonomies.
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